Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
Identification of a Primary Target of Thalidomide Teratogenicity
2010 StandoutScience
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Dendritic Cells as Vectors for Therapy
2001
The FGF family: biology, pathophysiology and therapy
2009 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes
2005 Standout
Lung Cancer
2008 Standout
Cancer immunotherapy: breaking the barriers to harvest the crop
2004 StandoutNobel
Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo
2002
Validation of Clinical Classification Schemes for Predicting Stroke
2001 Standout
Whither Ribosome Structure and Dynamics Research? (A Perspective)
2016 StandoutNobel
A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy
1990
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
Lone Atrial Fibrillation in Elderly Persons
1999
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
2005 StandoutNobel
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Dynamical features of thePlasmodium falciparumribosome during translation
2015 StandoutNobel
Platelet Activation and Atherothrombosis
2007 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
2005 Standout
High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C
1998 StandoutNobel
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
1993 Standout
The bleeding severity index: Validation and comparison to other methods for classifying bleeding complications of medical therapy
1989
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Photodynamic therapy and anti-tumour immunity
2006 Standout
Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses
2002
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Thalidomide
2004
Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer
2007
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
2010
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Current strategies in the management of hormone refractory prostate cancer
2003
Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer
2004
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Bleeding in outpatients treated with warfarin: relation to the prothrombin time and important remediable lesions
1989
Home Prothrombin Time Monitoring after the Initiation of Warfarin Therapy
1989
NF-κB as a therapeutic target in cancer
2002
Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial Fibrillation
2009
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Cancer immunotherapy with mRNA‐transfected dendritic cells
2004
Hemorrhagic Complications of Anticoagulant Treatment
2004
Tumor Angiogenesis
2008 Standout
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy
1989
Phase II Trial of Thalidomide for Therapy of Radioiodine-Unresponsive and Rapidly Progressive Thyroid Carcinomas
2007
Evaluation of a computer-assisted method for individualized anticoagulation: Retrospective and prospective studies with a pharmacodynamic model
1982
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell–mediated immunity via dendritic cells
2007 StandoutNobel
Splicing regulation by long noncoding RNAs
2018
Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy
1987
Improving Prospects for Targeting RAS
2015
Age-Related Risks of Long-term Oral Anticoagulant Therapy
1988
Long-Term Anticoagulant Therapy
1963
Clinical Significance of Hematuria in Patients on Anticoagulant Therapy
1987
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development
2011
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer
2008
Thalidomide Pharmacokinetics and Metabolite Formation in Mice, Rabbits, and Multiple Myeloma Patients
2004
EFFICACY OF PROPHYLACTIC GAMMA-GLOBULIN IN PREVENTING NON-A, NON-B POST-TRANSFUSION HEPATITIS
1976
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Survival of Creutzfeldt-Jakob-Disease Virus in Formol-Fixed Brain Tissue
1976 StandoutNobel
Management of Anticoagulation in Outpatients
1977
Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
1997 Standout
Hemorrhage during long-term anticoagulant drug therapy. 1. Intracranial hemmorrhage.
1966
A 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment.
1979
Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines
2016
Management of Oral Anticoagulant Therapy
1984
Dendritic Cells Charged with Apoptotic Tumor Cells Induce Long-Lived Protective CD4+ and CD8+ T Cell Immunity against B16 Melanoma
2003 StandoutNobel
Massive Hemorrhage Complicating Age-Related Macular Degeneration
1986
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
The translation elongation cycle—capturing multiple states by cryo-electron microscopy
2017 StandoutNobel
Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis.
1990 StandoutNobel
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
2009 StandoutNobel
Adoptive T cell therapy using antigen-specific CD8+T cell clones for the treatment of patients with metastatic melanoma:In vivopersistence, migration, and antitumor effect of transferred T cells
2002
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
Development of Chronic Liver Disease after Acute Non-A, Non-B Post-Transfusion Hepatitis
1977
Thalidomide for the Treatment of Cough in Idiopathic Pulmonary Fibrosis
2012
Idiopathic Pulmonary Fibrosis
2018 Standout
Works of Michael Hamilton being referenced
Pharmacokinetics of thalidomide in an elderly prostate cancer population
1999
Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers
2008
Deciphering the Plant Splicing Code: Experimental and Computational Approaches for Predicting Alternative Splicing and Splicing Regulatory Elements
2012
Problems Associated with Long-Term Anticoagulant Therapy
1962
Clinical Trial Designs for the Early Clinical Development of Therapeutic Cancer Vaccines
2001
Polysome profiling reveals translational control of gene expression in the human malaria parasite Plasmodium falciparum
2013
A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer.
2001
Clinical Trials of Hepatitis B Immune Globulin
1975